Candriam S.C.A.

Position in MEDP — Medpace Holdings, Inc.

CIK 1537014 STRASSEN, N4

Position in MEDP

as of Mar 31, 2026 · filed Apr 30, 2026 Compact

Position Value

$49,627,156

+$27,703,149 QoQ

Shares Held

103,349

+164.8% QoQ

Ownership

0.362%

of shares outstanding

% of Portfolio

0.26%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2022

13 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Candriam S.C.A. holds $593,505,748 across 14 Diagnostics & Research names. MEDP ranks #4 (8.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TMO	Thermo Fisher Scientific Inc.	354,087	$174,044,383
2	A	Agilent Technologies, Inc.	1,157,090	$131,885,118
3	DHR	Danaher Corp /De/	275,951	$52,320,309
4	MEDP	Medpace Holdings, Inc. This page	103,349	$49,627,156
5	IQV	Iqvia Holdings Inc.	226,794	$38,677,448
6	IDXX	Idexx Laboratories Inc /De	64,015	$35,969,388
7	MTD	Mettler Toledo International Inc/	21,458	$27,062,829
8	DGX	Quest Diagnostics Inc	104,136	$20,408,573

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$49,627,156	103,349	+164.8%	Shares	Sole	2026-04-30
2025-12-31	$21,924,007	39,035	+126.7%	Shares	Sole	2026-04-30
2025-09-30	$8,854,349	17,221	-66.7%	Shares	Sole	2025-11-06
2025-06-30	$16,212,438	51,655	-14.4%	Shares	Sole	2025-08-08
2025-03-31	$18,377,986	60,317	-1.4%	Shares	Sole	2025-05-14
2024-12-31	$20,329,817	61,192	-26.5%	Shares	Sole	2025-02-07
2024-09-30	$27,799,197	83,281	+11.7%	Shares	Sole	2024-11-13
2024-06-30	$30,707,947	74,561	+267.2%	Shares	Sole	2024-08-05
2024-03-31	$8,206,669	20,306	+253.1%	Shares	Sole	2024-05-06
2023-09-30	$1,392,247	5,750	-41.9%	Shares	Sole	2023-11-13
2023-06-30	$2,376,241	9,894	+164.8%	Shares	Sole	2023-08-08
2023-03-31	$702,742	3,737	-82.8%	Shares	Sole	2023-05-12
2022-09-30	$3,415,146	21,729	—	Shares	Sole	2022-11-10
No filing history on record for this holder in this stock.